Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Catalyst Investments is an Israeli multi-fund investment firm founded in 1999 that backs growth-stage and mature technology companies with an Israel nexus. The firm is not itself a drug developer, biotech company, or healthcare operating company; rather, it is an investor across multiple technology sectors, including life sciences, medtech, and biotechnology alongside software, cybersecurity, mobility, energy, and other fields. Catalyst positions itself as a long-term partner for growth and provides portfolio companies with capital, board-level support, international business networks, and access to cross-border capital markets and M&A expertise. Its newer vehicles, including Catalyst IV, focus on mature category-leading companies and may include life sciences among target sectors. Because it is an investment platform rather than a therapeutic developer, traditional biotech pipeline, modality, target, and indication fields are generally not applicable at the firm level.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Catalyst Investments.